Physician

Douglas B Smith, M.D.

According to 2025 Medicare claims, Douglas Smith, M.D. (NPI: 1407832025) practices rheumatology in the Indianapolis-Carmel-Greenwood, IN market, with the plurality of this provider's patient population coming from Marion, IN. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATES, P.C. (NPI: 1154452696; TIN: 35-1373436) and primary practice location at 46260-5307. Smith is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 509 traditional Medicare patients, billed 140,230 HCPCS/CPT codes, and received $1,771,999 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,816 prescription claims across 531 beneficiaries totaling $1,504,236 in drug costs, led by Enbrel (Etanercept). 2018 DME data shows 13 claims. Open Payments data shows 46 records totaling $2,106. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	681	62,989	$1,680,463
2016	640	75,724	$1,812,105
2017	598	88,901	$1,717,071
2018	568	79,809	$1,775,748
2019	522	68,514	$1,784,030
2020	500	84,188	$1,807,831
2021	489	102,734	$1,897,350
2022	467	100,109	$1,679,594
2023	523	130,156	$1,839,636
2024	509	140,230	$1,771,999

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	599	5,608	$1,394,500
2016	570	5,686	$1,973,570
2017	537	5,083	$1,428,456
2018	544	4,887	$1,854,370
2019	512	4,527	$1,597,558
2020	556	4,877	$1,630,536
2021	562	4,571	$1,934,307
2022	545	4,385	$1,873,887
2023	528	4,150	$1,715,440
2024	531	3,816	$1,504,236

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	13	$1,975
2018	N/R	13	$987
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	391	855	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	262	397	$11
80053	Blood test, comprehensive group of blood chemicals	274	494	$10
36415	Insertion of needle into vein for collection of blood sample	331	665	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	283	542	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel	Etanercept	30	1,036	$283,741
Enbrel Sureclick	Etanercept	31	868	$239,562
Rinvoq	Upadacitinib	23	1,050	$215,807
Humira(Cf) Pen	Adalimumab	22	672	$162,147
Benlysta	Belimumab	20	560	$91,588

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$2,106	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Douglas B. Smith, M.D.?

Tedicare shows public-source Medicare data for Douglas B. Smith, M.D. (NPI 1407832025), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Douglas B. Smith, M.D. have ACO affiliation data?

Douglas B. Smith, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Douglas B. Smith, M.D.?

Douglas B. Smith, M.D. is linked to RHEUMATOLOGY ASSOCIATES, P.C. (billing NPI 1154452696) in the available physician profile data.

Does Douglas B. Smith, M.D. have Open Payments data?

Douglas B. Smith, M.D. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.